Low incidence of abacavir hypersensitivity reaction among African children initiating antiretroviral therapy.
about
Efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV infected children and adolescents: a systematic review and meta-analysisRoutine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.First-line antiretroviral drug discontinuations in childrenAbacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial.Development of antiretroviral resistance in children with HIV in low- and middle-income countriesAntiviral efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV-infected children and adolescents: a systematic review protocol.
P2860
Low incidence of abacavir hypersensitivity reaction among African children initiating antiretroviral therapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Low incidence of abacavir hype ...... iating antiretroviral therapy.
@en
type
label
Low incidence of abacavir hype ...... iating antiretroviral therapy.
@en
prefLabel
Low incidence of abacavir hype ...... iating antiretroviral therapy.
@en
P2093
P50
P1476
Low incidence of abacavir hype ...... iating antiretroviral therapy.
@en
P2093
ARROW Trial Team
Adeodata Kekitiinwa
Bethany Naidoo
Jane Crawley
Kusum Nathoo
Patricia Nahirya-Ntege
Paula Munderi
Peter Mugyenyi
P304
P356
10.1097/INF.0B013E3182076864
P577
2011-06-01T00:00:00Z